Houston, TX, United States of America

Mayra Shanley

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: The University of Texas System. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mayra Shanley. Retrieved from https://idiyas.com/inventor/mayra-shanley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mayra Shanley: Innovator in Cell Immunotherapy

Introduction

Mayra Shanley is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of cancer treatment through her innovative work in cell immunotherapy. Her research focuses on utilizing immune effector cells to combat various types of cancer.

Latest Patents

Mayra Shanley holds a patent for her groundbreaking invention titled "Cell immunotherapy for the treatment of cancer." This patent encompasses compositions that include immune effector cells, such as natural killer (NK) cells. These cells are enhanced with one or more exogenously provided interleukins (IL), specifically IL-12, IL-21, or both, while excluding IL-15. The NK cells developed through her research can be utilized for the treatment of various cancers, including glioblastoma. She has 1 patent to her name.

Career Highlights

Mayra Shanley is affiliated with the University of Texas System, where she continues her research and development in immunotherapy. Her work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes.

Collaborations

Mayra collaborates with esteemed colleagues, including Katy Rezvani and David Marin Costa, who contribute to her research efforts and enhance the impact of her work.

Conclusion

Mayra Shanley is a trailblazer in the field of cell immunotherapy, with a focus on innovative treatments for cancer. Her contributions are paving the way for new therapeutic approaches that could significantly benefit patients in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…